ArticleFrontiers in medicine2026
Bilateral extensive adult-onset limbal xanthogranuloma invading the deep corneal stroma: a case report and literature review.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Adult-onset xanthogranuloma (AOXG) is a rare, benign form of non-Langerhans cell histiocytosis. Ocular manifestations commonly involve the orbit, uveal tract, or adnexal tissues; however, concurrent bilateral involvement accompanied by extensive infiltration of the corneoscleral limbus remains exceptionally rare and poses substantial diagnostic and therapeutic challenges. Case presentation: A 48-years-old male presented with a 20-years history of progressively enlarging bilateral, yellow-white corneoscleral lesions associated with severe visual impairment (right eye best-corrected visual acuity: 0.02). The patient subsequently underwent right eye corneal lesion excision combined with lamellar keratoplasty (LKP). Histopathological and immunohistochemical evaluation demonstrated a dense subepithelial infiltration of lipid-laden histiocytes and characteristic Touton giant cells, with immunoreactivity for CD68 and negative staining for S-100 and CD1a. Owing to the highly unusual bilateral presentation, a thorough systemic evaluation was initiated to exclude potentially lethal systemic histiocytoses, particularly Erdheim-Chester disease (ECD). Whole-body imaging revealed no evidence of visceral involvement or osteosclerotic lesions. Furthermore, molecular analysis confirmed a wild-type BRAF gene, while serum immunoelectrophoresis demonstrated no evidence of monoclonal gammopathy. Based on these comprehensive findings, a definitive diagnosis of AOXG was established. Following treatment, the patient demonstrated excellent anatomical resolution without evidence of recurrence and accompanied by a modest visual improvement to a BCVA of 0.1 throughout the 18-months follow-up period. Conclusion: Bilateral extensive limbal AOXG is a rare entity that can easily be misdiagnosed as corneal degeneration, squamous cell carcinoma, or sclerocornea. Persistent chronic inflammation alongside hyperlipidemia may have contributed to the disease's etiology. Regarding lesions exhibiting deep stromal invasion, integrating LKP with intralesional corticosteroid administration may be a useful therapeutic approach in selected vision-threatening cases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.